BMO Capital Maintains Outperform on Celestica, Raises Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Thanos Moschopoulos has maintained an Outperform rating on Celestica (NYSE:CLS) and increased the price target from $32 to $37, indicating a positive outlook on the company's stock performance.
January 31, 2024 | 5:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BMO Capital analyst has reaffirmed an Outperform rating on Celestica and raised the price target from $32 to $37, suggesting confidence in the company's future performance.
The increase in price target by a reputable analyst typically signals a bullish outlook on the stock, which can lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100